Loading provider…
Loading provider…
Hematology & Oncology Physician in Tampa, FL
NPI: 1275635971Primary Employer
Moffitt Medical Group
moffitt.org
HQ Phone
Get MD Hatem's Phone Numberphone_androidMobile
Get MD Hatem's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2004 - 2027

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Medical College of Georgia
augusta.edu
Medical School
Until 2002
University of South Florida Morsani College of Medicine/Moffitt Cancer Center/Tampa General Hospital
Fellowship • Hematology and Medical Oncology
2005 - 2008
University of South Florida Morsani
Residency • Internal Medicine
2002 - 2005
University of Georgia Athens
BS • 1996
Until 1996
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 79 | 147 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 24 | 24 |
Metastatic Breast Cancer, Version 1.2012 Featured Updates to the NCCN Guidelines
Authors: Clifford Hudis, Richard Theriault, George Somlo, Benjamin Anderson, Beryl Mccormick, Britt-Marie Ljung, Robert Carlson, David Mankoff
Journal: J Natl Compr Canc Netw
Developing an effective breast cancer vaccine.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Cancer Control
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Florida Breast Cancer Foundation
Intervention / Treatment: DIAGNOSTIC_TEST: Magnetic Resonance Imaging
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Eli Lilly and Company
Intervention / Treatment: DRUG: Abemaciclib, DRUG: Endocrine therapy, RADIATION: Stereotactic Radiosurgery (SRS)
Lead Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Intervention / Treatment: DRUG: fulvestrant, DRUG: tucatinib, DRUG: trastuzumab